Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -3.96% | 58.19 | 0.0% | $1899.37m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.26% | 597.00 | 2.5% | $1174.48m | |
| GILD | Gilead Sciences, Inc. | -1.02% | 76.75 | 1.0% | $975.82m | |
| AMGN | Amgen, Inc. | 2.17% | 225.67 | 1.3% | $660.44m | |
| NVAX | Novavax, Inc. | 3.67% | 46.30 | 102.0% | $655.72m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -2.61% | 265.69 | 1.9% | $544.78m | |
| ILMN | Illumina, Inc. | -1.20% | 354.11 | 3.5% | $388.06m | |
| BIIB | Biogen, Inc. | 2.36% | 306.72 | 1.6% | $378.26m | |
| SRNE | Sorrento Therapeutics, Inc. | 6.74% | 4.12 | 1.8% | $269.11m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.35% | 115.21 | 2.0% | $241.70m | |
| SGEN | Seattle Genetics, Inc. | -1.36% | 148.39 | 6.1% | $223.95m | |
| A | Agilent Technologies, Inc. | -0.83% | 90.38 | 1.6% | $215.81m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.59% | 105.80 | 4.3% | $184.97m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.06% | 147.99 | 13.9% | $156.63m | |
| INCY | Incyte Corp. | -0.31% | 93.51 | 2.5% | $153.41m |
Company Profile
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, ophthalmic, and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types; TRC205 created for the treatment of fibrotic diseases; and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. The company was founded in October 2004 and is headquartered in San Diego, CA.